Chronic Diseases

- Pininvest Analysis
The chronic diseases to which our theme pays special attention are diabetes, kidney-failure, hypertension and respiratory disorders
Most – if not all these life threatening conditions – are related to changing life styles and consumption patterns, both in developed and developing countries, becoming a stark challenge for health care organizations and governments worldwide
The health care firms providing medication – and medical devices - for these chronic diseases have developed a business model setting the companies apart from the pharmaceutical majors in a long term strategy
- Gaining traction in developing countries, one market at a time, the most successful firms have learned how to fit in – always very distinct – local healthcare organizations and to account for insurance coverage systems (where they exist)
- Education of healthcare professionals by the industry leaders has gone beyond marketing efforts – especially in emerging markets
Chronic Diseases • Updated:
Name | Ticker | Exchange | Sector | Industry | Currency | Cur.Price | Mkt.Cap | Perf. | Vol. | Risk Contrib. | MDD |
|
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abiomed | ABMD | NASDAQ | Health Care | Medical Devices | USD | 323.78 | 15 B | 103.9% | 43% | 4% | -21% |
|
|
AngioDynamics | ANGO | NASDAQ | Health Care | Medical Devices | USD | 20.51 | 777 M | 68.0% | 66% | 7% | -32% |
|
|
Baxter International Inc. | BAX | NYSE | Health Care | Kidney Failure | USD | 78.51 | 40 B | -8.7% | 37% | 3% | -21% |
|
|
Boston Scientific Corp. | BSX | NYSE | Health Care | Medical Devices | USD | 39.53 | 57 B | -1.0% | 45% | 5% | -35% |
|
|
Cardiovascular Systems | CSII | NASDAQ | Health Care | Medical Devices | USD | 42.29 | 1.7 B | 9.4% | 52% | 5% | -35% |
|
|
DaVita | DVA | NYSE | Health Care | Kidney Failure | USD | 102.89 | 12 B | 26.9% | 42% | 4% | -19% |
|
|
Dexcom | DXCM | NASDAQ | Health Care | Diabetes | USD | 405.64 | 39 B | 42.9% | 55% | 5% | -31% |
|
|
Edwards Lifesciences Corp. | EW | NYSE | Health Care | Medical Devices | USD | 84.45 | 53 B | 13.1% | 43% | 5% | -30% |
|
|
Fisher & Paykel Healthcare | FSPKF | OTC | Health Care | Respiratory Disorders | USD | 22.51 | - | 40.1% | 42% | 2% | -13% |
|
|
Fresenius Medical Care | FMS | NYSE | Health Care | Kidney Failure | USD | 35.36 | 22 B | -7.9% | 34% | 3% | -26% |
|
|
Insulet | PODD | NASDAQ | Health Care | Diabetes | USD | 262.36 | 17 B | 33.4% | 51% | 5% | -34% |
|
|
Itamar Medical | ITMMF | OTC | Health Care | Respiratory Disorders | USD | 0.95 | - | 90.0% | 140% | 6% | -43% |
|
|
Lexicon Pharmaceuticals | LXRX | NASDAQ | Health Care | Diabetes | USD | 7.75 | 830 M | 171.8% | 125% | 9% | -63% |
|
|
MannKind Corporation | MNKD | NASDAQ | Health Care | Diabetes | USD | 5.98 | 1.4 B | 343.0% | 89% | 9% | -23% |
|
|
Novo Nordisk | NVO | NYSE | Health Care | Diabetes | USD | 72.19 | 170 B | 21.2% | 31% | 3% | -24% |
|
|
Oramed Pharmaceuticals | ORMP | NASDAQ | Health Care | Diabetes | USD | 9.37 | 220 M | 92.4% | 83% | 5% | -21% |
|
|
ResMed | RMD | NYSE | Health Care | Respiratory Disorders | USD | 200.97 | 29 B | 21.9% | 49% | 5% | -35% |
|
|
Rockwell Medical | RMTI | NASDAQ | Health Care | Kidney Failure | USD | 1.49 | 105 M | -52.1% | 100% | 10% | -76% |
|
|
SomnoMed | SOMNF | OTC | Health Care | Respiratory Disorders | USD | 1.45 | - | -33.2% | 135% | 4% | -70% |
|